| HOME >> BIOLOGY >> TECHNOLOGY |
ROCKVILLE, Md. and NEWTON, Mass., April 17 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX), providing Med-ePhone(TM), Med-eMonitor(TM), and Med-eXpert(TM) Systems to improve medication adherence and health status monitoring, and InnovationRx, a provider of prescription medication adherence solutions, announced an agreement to market and sell a combined product line to a broad spectrum of Federal and State Governmental Agencies, insurance companies, health plans, managed care companies, disease management organizations, and other related private and public industry organizations and plans.
InnovationRx, the healthcare division of Innovation Group, employs an inter-disciplinary, multi-modal methodology to assess and improve medication adherence, which provides clinical evaluation, customized interventions and progress reports. Their services, developed in a research grant partnership with Northeastern University School of Pharmacy, are anchored by proprietary medication adherence risk-assessment instruments and intervention plans, combined with interactive Web-based tools and live pharmacists in call centers. These licensed pharmacists, trained in motivational interviewing and compliance, provide patients with personalized, one-to-one support and consultation. Innovation Group is a global company with revenues in excess of $250 million and is focused on providing risk management business solutions to various industries and marketplaces throughout the world.
The companies are collaborating to create discrete combinations of
their respective products and services that address differing levels of
adherence risk among low risk, medium risk, and high risk populations.
Specifically combined product and service offerings will be developed,
marketed and sold at specific price points. The combinations will be
designed to provide the right mix of products and services to best achieve
improved medication adherence, health outco
'/>"/>
| SOURCE InforMedix Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |